A Mass Balance Study of [14C]-IPN60250 in Healthy Adult Participants
CLIN-60250-451
Phase 1 other active
Quick answer
A Mass Balance Study of [14C]-IPN60250 in Healthy Adult Participants for Primary sclerosing cholangitis (PSC) is a Phase 1 program (other) at Ipsen Pharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ipsen Pharma
- Indication
- Primary sclerosing cholangitis (PSC)
- Phase
- Phase 1
- Modality
- other
- Status
- active